{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T04:58:33Z","timestamp":1787979513364,"version":"build-2784847793"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"ICMR-National Institute of Immunohematology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Acquired aplastic anemia (AA) often results from immune destruction of hematopoietic stem and progenitor cells. However, only 60%\u201370% of patients with AA respond to immunosuppressive therapy (IST). There is a lack of strong predictive markers for response to IST which can help therapy. Our study sought to pinpoint unique immune markers in AA patients and validate established predictors for response to IST. We enrolled 51 severe AA patients and analyzed 57 immunological parameters via flow cytometry. Additionally, we measured paroxysmal nocturnal hemoglobinuria (PNH) clone, telomere length, and thrombopoietin (TPO) levels prior to IST. After a 6-month follow-up, a response was observed. Patients with AA had a distinct immunological signature characterized by absolute lymphopenia, skewed CD4\/CD8 ratio with expansion of CD8 T cells with activated and senescent phenotype. Treg counts were reduced, while the proportion of Treg A and B was comparable to controls. Treatment response was correlated with elevated absolute neutrophil count (ANC), absolute reticulocyte count (ARC), and reduced CD57+ CD8+ naive cells and B cell % before therapy. However, predictors like TPO, telomere length, and PNH did not emerge as indicators of treatment response. Identifying predictors for treatment response in AA is challenging due to abnormal hematopoiesis, genetic mutations, and treatment variables.<\/jats:p>","DOI":"10.1093\/cei\/uxae076","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T12:08:59Z","timestamp":1723550939000},"page":"291-299","source":"Crossref","is-referenced-by-count":5,"title":["Unveiling immunological signatures and predictors of response to immunosuppressive therapy in acquired aplastic anemia"],"prefix":"10.1093","volume":"218","author":[{"given":"Maya","family":"Gupta","sequence":"first","affiliation":[{"name":"Paediatric Immunology and Leucocytes Biology Department, ICMR-National Institute of Immunohematology , Mumbai,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrakala","family":"Shanmukhaiah","sequence":"additional","affiliation":[{"name":"Haematology Department, King Edward Memorial Hospital (KEM Hospital) , Mumbai,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babu Rao","family":"Vundinti","sequence":"additional","affiliation":[{"name":"Paediatric Immunology and Leucocytes Biology Department, ICMR-National Institute of Immunohematology , Mumbai,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrutha","family":"Jose","sequence":"additional","affiliation":[{"name":"Paediatric Immunology and Leucocytes Biology Department, ICMR-National Institute of Immunohematology , Mumbai,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashank","family":"Tiwari","sequence":"additional","affiliation":[{"name":"Mathematics Department, Institute of Chemical Technology (ICT) , Mumbai,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amiya","family":"Bhowmick","sequence":"additional","affiliation":[{"name":"Mathematics Department, Institute of Chemical Technology (ICT) , Mumbai,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6380-3116","authenticated-orcid":false,"given":"Manisha","family":"Madkaikar","sequence":"additional","affiliation":[{"name":"Paediatric Immunology and Leucocytes Biology Department, ICMR-National Institute of Immunohematology , Mumbai,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"key":"2024111307581327100_CIT0001","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMra1413485","article-title":"Aplastic Anaemia","volume":"379","author":"Young","year":"2018","journal-title":"N Engl J Med"},{"key":"2024111307581327100_CIT0002","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/j.seminhematol.2021.12.002","article-title":"Aplastic anemia: pathophysiology","volume":"59","author":"Giudice","year":"2022","journal-title":"Semin Hematol"},{"key":"2024111307581327100_CIT0003","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3324\/haematol.2017.176701","article-title":"Deep sequencing and flow cytometric characterization of expanded effector memory CD8 + CD57 + T cells frequently reveals T-cell receptor V\u03b2 oligoclonality and CDR3 homology in acquired aplastic anemia","volume":"103","author":"Giudice","year":"2018","journal-title":"Haematologica"},{"key":"2024111307581327100_CIT0004","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.imlet.2017.01.016","article-title":"High programmed death 1 expression on T cells in aplastic anemia","volume":"183","author":"Zhao","year":"2017","journal-title":"Immunol Lett"},{"key":"2024111307581327100_CIT0005","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1182\/blood-2018-99-115120","article-title":"Increased age-related B-Cells in patients with aplastic anemia","volume":"29","author":"Solomou","year":"2018","journal-title":"Blood"},{"key":"2024111307581327100_CIT0006","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/bjh.16651","article-title":"Deficit of circulating CD19+ CD24hi CD38hi regulatory B cells in severe aplastic anaemia","volume":"190","author":"Zaimoku","year":"2020","journal-title":"Br J Haematol"},{"key":"2024111307581327100_CIT0007","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1182\/blood.V67.5.1349.1349","article-title":"Analysis of natural killer cells in patients with aplastic anemia","volume":"67","author":"Gascon","year":"1986","journal-title":"Blood"},{"key":"2024111307581327100_CIT0008","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood-2016-08-693481","article-title":"How I treat acquired aplastic anemia","volume":"129","author":"Bacigalupo","year":"2017","journal-title":"Blood"},{"key":"2024111307581327100_CIT0009","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-0609.2009.01378.x","article-title":"Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia","volume":"84","author":"Chang","year":"2010","journal-title":"Eur J Haematol"},{"key":"2024111307581327100_CIT0010","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3324\/haematol.2021.278413","article-title":"Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag","volume":"107","author":"Zaimoku","year":"2022","journal-title":"Haematologica"},{"key":"2024111307581327100_CIT0011","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-2141.2006.06085.x","article-title":"Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil","volume":"133","author":"Scheinberg","year":"2006","journal-title":"Br J Haematol"},{"key":"2024111307581327100_CIT0012","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3892\/mmr.2014.2344","article-title":"CD8+HLA-DR+ T cells are increased in patients with severe aplastic anemia","volume":"10","author":"Xing","year":"2014","journal-title":"Mol Med Rep"},{"key":"2024111307581327100_CIT0013","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1002\/eji.201343751","article-title":"The who\u2019s who of T-cell differentiation: human memory T-cell subsets","volume":"43","author":"Mahnke","year":"2013","journal-title":"Eur J Immunol"},{"key":"2024111307581327100_CIT0014","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3324\/haematol.2018.190884","article-title":"(Auto-)immune signature in aplastic anemia","volume":"103","author":"Risitano","year":"2018","journal-title":"Haematologica"},{"key":"2024111307581327100_CIT0015","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1182\/blood-2016-03-703702","article-title":"Deep phenotyping of tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment","volume":"128","author":"Kordasti","year":"2016","journal-title":"Blood"},{"key":"2024111307581327100_CIT0016","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1046\/j.1365-2141.2002.03875.x","article-title":"Selective reduction of natural killer T cells in the bone marrow of aplastic anaemia","volume":"119","author":"Zeng","year":"2002","journal-title":"Br J Haematol"},{"key":"2024111307581327100_CIT0017","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cellimm.2017.03.003","article-title":"Decreased TIM-3 expression of peripheral blood natural killer cells in patients with severe aplastic anemia","volume":"318","author":"Zhang","year":"2017","journal-title":"Cell Immunol"},{"key":"2024111307581327100_CIT0018","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/bjh.15650","article-title":"The effect of age in patients with acquired aplastic anaemia treated with immunosuppressive therapy: comparison of adolescents and young adults with children and older adults","volume":"183","author":"Cabannes-Hamy","year":"2018","journal-title":"Br J Haematol"},{"key":"2024111307581327100_CIT0019","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00277-015-2348-5","article-title":"The role of paroxysmal nocturnal hemoglobinuria clones in response to immunosuppressive therapy of patients with severe aplastic anemia","volume":"94","author":"Zhao","year":"2015","journal-title":"Ann Hematol"},{"key":"2024111307581327100_CIT0020","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/bjh.12661","article-title":"Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study","volume":"164","author":"Kulagin","year":"2014","journal-title":"Br J Haematol"},{"key":"2024111307581327100_CIT0021","first-page":"4964","article-title":"Telomere length is significantly reduced in patients with aplastic anemia and is not influenced by gender and severity","volume":"130","author":"Edison","year":"2017","journal-title":"Blood"},{"issue":"10","key":"2024111307581327100_CIT0022","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1073\/pnas.1720427115","article-title":"Diagnostic utility of telomere length testing in a hospital-based setting","volume":"115","author":"Alder","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024111307581327100_CIT0023","first-page":"7.26.1","article-title":"Assessment of telomere length, phenotype, and DNA content","volume":"79","author":"Kelesidis","year":"2017","journal-title":"Curr Protoc Cytom"},{"key":"2024111307581327100_CIT0024","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1056\/NEJMoa1515319","article-title":"Danazol treatment for telomere diseases","volume":"374","author":"Townsley","year":"2016","journal-title":"N Engl J Med"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cei\/advance-article-pdf\/doi\/10.1093\/cei\/uxae076\/59029464\/uxae076.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/218\/3\/291\/60630280\/uxae076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/218\/3\/291\/60630280\/uxae076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T11:28:38Z","timestamp":1731497318000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/218\/3\/291\/7732537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,8,13]]},"published-print":{"date-parts":[[2024,11,12]]}},"URL":"https:\/\/doi.org\/10.1093\/cei\/uxae076","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,8,13]]}}}